Saturday 17 October 2026
Export MDT’s income statement to Excel — free account
Medtronic PLC
MDT Healthcare Medical Devices
Medtronic PLC’s revenue for fiscal 2026 (year ended April 2026) was $36.4 billion, up 8.43% from fiscal 2025. In the quarter to July 2026, revenue grew 13.7%, EPS grew 42.0%, free cash flow grew 120.9% and total debt fell 1.59%, each against the same quarter a year earlier. Member of the S&P 500; dividend growth for ten consecutive years, revenue growth for three, operating cash flow growth for three.
94.75
0.70
−0.73%
Follow MDT
| Apr '26 | Apr '25 | Apr '24 | Apr '23 | Apr '22 | Apr '21 | Apr '20 | Apr '19 | Apr '18 | Apr '17 | |
|---|---|---|---|---|---|---|---|---|---|---|
Piotroski F-Score |
7 | 6 | 6 | 5 | 8 | 5 | 6 | 8 | 8 | 8 |
P/E ratio |
21.65 | 23.35 | 29.18 | 32.04 | 27.50 | 49.03 | 27.35 | 25.82 | 34.99 | 28.58 |
Altman Z-Score |
2.73 | 2.71 | 2.79 | 3.02 | 3.36 | 3.64 | 3.05 | 2.98 | 2.72 | 2.32 |
P/S ratio |
2.85 | 3.25 | 3.29 | 3.86 | 4.37 | 5.85 | 4.53 | 3.91 | 3.63 | 3.89 |
Altman Z″-Score (non-manufacturers) |
3.76 | 3.51 | 3.64 | 3.79 | 3.72 | 3.62 | 3.55 | 3.75 | 3.60 | 2.89 |
P/FCF ratio |
19.13 | 21.02 | 20.49 | 26.33 | 23.16 | 36.04 | 21.74 | 20.36 | 30.06 | 20.52 |
P/Operating CF |
40.34 | 43.10 | 38.36 | 49.02 | 67.31 | 100.90 | 90.27 | 57.29 | 104.73 | 65.13 |
Beneish M-Score |
(2.58) | (2.58) | (2.63) | (2.50) | (2.59) | (2.44) | (2.82) | (2.56) | (2.47) | (2.65) |
Dividend Safety Score |
61 | — | — | — | — | — | — | — | — | — |
P/B ratio |
2.07 | 2.26 | 2.11 | 2.33 | 2.63 | 3.41 | 2.57 | 2.38 | 2.14 | 2.29 |
Price to Tangible BV |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
EV/Sales |
3.37 | 3.83 | 3.82 | 4.39 | 4.80 | 6.36 | 5.01 | 4.42 | 4.11 | 4.55 |
EV/EBITDA |
13.00 | 14.58 | 15.86 | 16.74 | 17.97 | 26.67 | 19.42 | 15.13 | 13.27 | 16.29 |
EV/Operating CF |
16.72 | 18.25 | 18.20 | 22.68 | 20.69 | 30.71 | 20.01 | 19.27 | 26.31 | 19.65 |
EV/FCF |
22.58 | 24.79 | 23.76 | 29.91 | 25.43 | 39.23 | 24.04 | 23.00 | 34.08 | 24.03 |
Quick Ratio |
1.36 | 1.20 | 1.31 | 1.54 | 1.30 | 1.91 | 1.50 | 1.90 | 1.71 | 1.35 |
Current Ratio |
2.13 | 1.85 | 2.03 | 2.39 | 1.86 | 2.65 | 2.13 | 2.59 | 2.28 | 1.74 |
Net Debt/EBITDA |
1.99 | 2.22 | 2.18 | 2.01 | 1.60 | 2.17 | 1.86 | 1.73 | 1.57 | 2.38 |
Debt/Assets |
30.06% | 31.10% | 27.81% | 26.79% | 26.50% | 28.35% | 27.34% | 28.23% | 28.18% | 33.49% |
Debt/Equity |
0.56 | 0.59 | 0.50 | 0.47 | 0.46 | 0.51 | 0.49 | 0.50 | 0.51 | 0.66 |
Asset Turnover |
0.39 | 0.37 | 0.36 | 0.34 | 0.34 | 0.33 | 0.32 | 0.34 | 0.31 | 0.30 |
Operating CF/Net income |
1.53 | 1.51 | 1.85 | 1.61 | 1.46 | 1.73 | 1.51 | 1.51 | 1.51 | 1.71 |
Capex/Depreciation |
(0.64) | (0.65) | (0.60) | (0.54) | (0.51) | (0.50) | (0.46) | (0.43) | (0.40) | (0.43) |
Interest Coverage |
9.04 | 8.17 | 7.16 | 8.62 | 10.40 | 4.85 | 4.39 | 4.34 | 5.79 | 4.92 |
| 9.77% | 9.45% | 7.20% | 7.20% | 9.66% | 7.04% | 9.48% | 9.17% | 6.14% | 7.87% | |
| 5.20% | 5.13% | 4.06% | 4.13% | 5.48% | 3.92% | 5.31% | 5.11% | 3.25% | 4.04% | |
ROIC |
5.87% | 5.49% | 4.77% | 5.04% | 5.43% | 4.17% | 4.63% | 5.96% | 6.35% | 4.80% |
Return on Tangible Assets |
23.37% | 26.23% | 21.28% | 20.66% | 31.34% | 18.72% | 29.04% | 25.49% | 17.74% | 26.91% |
Average Days of Receivables |
66.68 | 70.91 | 69.11 | 70.11 | 63.94 | 66.20 | 58.64 | 74.32 | 72.96 | 68.69 |
Research and Development Expense of Revenue |
7.90% | 8.15% | 8.45% | 8.63% | 8.67% | 8.28% | 8.06% | 7.63% | 7.53% | 7.38% |
Selling, General and Administrative Expense of Revenue |
32.41% | 32.35% | 33.17% | 33.35% | 32.48% | 33.70% | 34.96% | 34.09% | 34.18% | 33.72% |
Intangible Assets out of Total Assets |
0.57 | 0.58 | 0.60 | 0.62 | 0.62 | 0.64 | 0.65 | 0.67 | 0.67 | 0.62 |
Share Based Compensation of Revenue |
1.26% | 1.28% | 1.21% | 1.14% | 1.13% | 1.14% | 1.03% | 0.95% | 1.15% | 1.17% |
Graham Net Nets |
(0.18) | (0.18) | (0.17) | (0.15) | (0.11) | (0.11) | (0.14) | (0.15) | (0.16) | (0.21) |
Graham Number |
57.33 | 55.37 | 48.47 | 49.74 | 57.57 | 48.01 | 55.21 | 53.73 | 43.93 | 49.05 |
Earnings Yield |
4.62% | 4.28% | 3.43% | 3.12% | 3.64% | 2.04% | 3.66% | 3.87% | 2.86% | 3.50% |
Free Cash Flow Yield |
5.23% | 4.76% | 4.88% | 3.80% | 4.32% | 2.77% | 4.60% | 4.91% | 3.33% | 4.87% |
Revenue per Share |
28.37 | 26.09 | 24.38 | 23.48 | 23.60 | 22.39 | 21.57 | 22.70 | 22.08 | 21.55 |
Operating CF per Share |
5.72 | 5.48 | 5.11 | 4.54 | 5.47 | 4.64 | 5.40 | 5.20 | 3.45 | 4.99 |
Capex per Share |
(1.49) | (1.45) | (1.20) | (1.10) | (1.02) | (1.01) | (0.90) | (0.84) | (0.79) | (0.91) |
Free Cash Flow per Share |
4.23 | 4.03 | 3.92 | 3.44 | 4.45 | 3.63 | 4.49 | 4.36 | 2.67 | 4.08 |
Cash per Share |
7.19 | 6.97 | 6.03 | 5.99 | 7.88 | 8.04 | 8.17 | 7.31 | 8.28 | 9.94 |
Shareholders Equity per Share |
39.06 | 37.54 | 37.98 | 38.85 | 39.27 | 38.37 | 37.94 | 37.29 | 37.46 | 36.50 |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
39.06 | 37.54 | 37.98 | 38.85 | 39.27 | 38.37 | 37.94 | 37.29 | 37.46 | 36.50 |
Free Cash Flow |
5,426.00 | 5,185.00 | 5,200.00 | 4,580.00 | 5,978.00 | 4,885.00 | 6,021.00 | 5,873.00 | 3,616.00 | 5,626.00 |
Working Capital |
13,129.00 | 10,935.00 | 11,146.00 | 12,624.00 | 10,665.00 | 14,039.00 | 11,665.00 | 13,495.00 | 12,896.00 | 10,609.00 |
Capital Expenditures |
(1,904.00) | (1,859.00) | (1,587.00) | (1,459.00) | (1,368.00) | (1,355.00) | (1,213.00) | (1,134.00) | (1,068.00) | (1,254.00) |
Net Current Asset Value |
(18,169.00) | (19,610.00) | (17,626.00) | (17,608.00) | (15,201.00) | (18,933.00) | (17,786.00) | (17,515.00) | (17,591.00) | (24,654.00) |
EV/EBIT |
18.95 | 21.58 | 24.01 | 24.98 | 26.42 | 42.74 | 30.21 | 21.55 | 18.56 | 25.12 |
Capex to Sales |
0.05 | 0.06 | 0.05 | 0.05 | 0.04 | 0.05 | 0.04 | 0.04 | 0.04 | 0.04 |
Price to Operating Income |
16.05 | 18.30 | 20.71 | 21.98 | 24.07 | 39.27 | 27.32 | 19.08 | 16.37 | 21.45 |
| Other line items | ||||||||||
Depreciation/Fixed assets |
0.40 | 0.42 | 0.43 | 0.48 | 0.50 | 0.52 | 0.55 | 0.57 | 0.57 | 0.67 |
Cash ROIC |
6.22% | 6.05% | 6.23% | 5.45% | 6.84% | 5.50% | 6.95% | 6.88% | 4.12% | 5.77% |
Accounts Receivable Turnover |
5.53 | 5.31 | 5.34 | 5.41 | 5.75 | 5.96 | 5.32 | 5.01 | 5.17 | 5.33 |
Accounts Payable Turnover |
5.00 | 4.79 | 4.42 | 4.34 | 4.63 | 5.11 | 4.77 | 5.11 | 5.70 | 5.69 |
Inventory Turnover |
2.23 | 2.18 | 2.13 | 2.16 | 2.27 | 2.45 | 2.36 | 2.50 | 2.62 | 2.73 |
Average Days of Payables |
75.86 | 76.85 | 78.43 | 90.65 | 81.89 | 73.33 | 77.31 | 77.86 | 65.54 | 61.07 |
Days of Inventory on Hand |
170.75 | 171.83 | 169.78 | 180.24 | 166.08 | 150.17 | 163.79 | 149.63 | 144.08 | 131.09 |
Average Receivables |
6,579.00 | 6,321.50 | 6,063.00 | 5,774.50 | 5,506.50 | 5,053.50 | 5,433.50 | 6,104.50 | 5,789.00 | 5,576.50 |
Average Payables |
2,546.50 | 2,429.50 | 2,536.00 | 2,469.00 | 2,191.00 | 2,051.00 | 1,974.50 | 1,790.50 | 1,591.50 | 1,632.00 |
Average Inventory |
5,713.50 | 5,346.50 | 5,255.00 | 4,954.50 | 4,464.50 | 4,271.00 | 3,991.00 | 3,666.00 | 3,458.50 | 3,405.50 |
Average Assets |
92,354.00 | 90,830.50 | 90,464.50 | 90,964.50 | 92,032.00 | 91,886.00 | 90,191.50 | 90,543.50 | 95,625.00 | 99,750.50 |
Average Common Equity |
49,164.50 | 49,338.50 | 51,042.50 | 52,193.50 | 52,162.00 | 51,237.00 | 50,542.00 | 50,517.00 | 50,576.00 | 51,196.50 |
Columns are period end dates